ReFlow Medical Corporation Announces FDA 510(k) Clearance and Initial US Clinical Use Of The Wingman35 Crossing Catheter

ReFlow Medical, Inc. today announced FDA clearance for US commercialization of their Wingman35 Crossing Catheter for use in the peripheral vasculature as well as the first US clinical cases with the device.



from Content Keyword RSS http://ift.tt/1rm6FzJ

via IFTTT